← Leaderboards
Fritz H Bach
Beth Israel Deaconess Medical Center
$2,929,318
Attributed
$2,929,318
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $425K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,929,318 · 4
By mechanism
R01$2,919,318 · 3
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Barbara Wegiel$4,886,655
- Maria Serena Longhi$3,119,696
- Aarti Asnani$3,921,462
- Shahzad Shaefi$1,037,940
- Vassiliki A Boussiotis$19,288,605
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisMonocyteCarbon MonoxideCell Adhesion MoleculesStressInflammationVascular EndotheliumNuclear Factor Kappa BetaGene ExpressionTranscription FactorAllogenicBiliverdineBiliverdin ReductaseAortic SegmentBilirubinAnti-Inflammatory AgentsAbbreviationsAnti-InflammatoryArteriosclerosisEndothelial CellsCellsAtherosclerosisChronicBone Marrow Transplantation
Grant awards (9)
Heme Oxygenase-1: protection against chronic rejection$412,675
R01 · FY2009 · HL · contact PI
Heme Oxygenase-1: protection against chronic rejection$412,675
R01 · FY2008 · HL · contact PI
Heme Oxygenase-1: protection against chronic rejection$412,675
R01 · FY2007 · HL · contact PI
Heme Oxygenase-1: protection against chronic rejection$425,000
R01 · FY2006 · HL · contact PI
Heme Oxygenase 2005 -- the 4th International Conference$10,000
R13 · FY2005 · HL
Regulation of Endothleial Cell Apoptosis by HO-1 and CO$297,500
R01 · FY2004 · HL
Regulation of Endothleial Cell Apoptosis by HO-1 and CO$297,500
R01 · FY2003 · HL
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS$334,150
R01 · FY2001 · HL
XENOTRANSPLANT--GENETICALLY ENGINEERED ENDOTHELIAL CELLS$327,143
R01 · FY2000 · HL